Most Recent

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

Online scientific journals are sacrificing the quality of research articles to make a buck.

2 Comments

image: Opinion: #IceBucketChallenge, Investing Well

Opinion: #IceBucketChallenge, Investing Well

By | September 10, 2014

Hundreds of thousands participated in the ALS campaign that went viral, but how are they supposed to decide where to donate?

3 Comments

image: Opinion: Diagnostics for NTDs

Opinion: Diagnostics for NTDs

By | August 25, 2014

Developing treatments for neglected tropical diseases is only half the battle.

0 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Opinion: Research, Restricted

Opinion: Research, Restricted

By | July 8, 2013

Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?

4 Comments

image: Opinion: The Present and Future of Neurogenomics

Opinion: The Present and Future of Neurogenomics

By | June 13, 2013

Support the BRAIN Initiative, but don’t overlook the neurogenomic diagnostics that are already driving breakthroughs in brain and rare neurological disorders.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: Opinion: Health Booth 2020

Opinion: Health Booth 2020

By | February 4, 2013

Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech